Background Acute inflammatory responses during and after percutaneous coronary intervention (PCI) are associated with subsequent cardiovascular event risk, but limited data exist on acute immune cell ...

People with a buildup of fatty atherosclerotic plaque in the heart's arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent percutaneous ...

Diabetes mellitus was a significant predictor of adverse cardiovascular outcomes following PCI for left main bifurcation ...

Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...

Based on available data, the benchmark for a timely PCI intervention has become a D2B time of less than 90 minutes. In an effort to improve the timeliness of primary PCI, the D2B Alliance campaign ...

The intensity of antiplatelet therapy during percutaneous coronary intervention (PCI) is an important determinant of PCI-related ischemic complications. Cangrelor is a potent intravenous adenosine ...

A meta-analysis of long-term data suggests that both drug-eluting stent percutaneous coronary intervention (DES-PCI) and ...

Facilitated percutaneous coronary intervention (PCI) refers to using fibrinolytic therapy to stabilize the patient while transport is being arranged to a primary PCI facility. This strategy receives a ...

Certification to perform catheter-based interventions for coronary artery disease was originally limited to hospitals that had the capability to perform cardiac surgery on site. However, there has ...